Ivermectin's price has seen significant fluctuations, particularly in recent years.
What Influenced Ivermectin Prices Recently?
The demand for ivermectin surged dramatically in late 2020 and 2021 due to its investigation as a potential treatment for COVID-19 [1]. This increased interest, often fueled by social media and anecdotal reports, led to a sharp rise in both demand and price [2]. However, regulatory bodies and major health organizations, including the U.S. Food and Drug Administration (FDA), have stated that ivermectin is not an approved or recommended treatment for COVID-19 [3][4]. As clinical evidence did not support its efficacy for COVID-19 and many countries and health systems discouraged its use for this indication, demand subsequently declined [2].
How Does Ivermectin's Price Vary by Formulation?
Ivermectin is available in various formulations, including tablets, topical creams, and lotions. The price can differ based on the specific formulation, dosage, and whether it is a branded or generic product [5].
Are There Different Prices for Human vs. Veterinary Ivermectin?
Yes, ivermectin is used in both human and veterinary medicine for treating parasitic infections [6]. The pricing for veterinary formulations can differ from those intended for human use.
Where Can I Find Current Ivermectin Pricing Information?
Information on drug pricing, including ivermectin, can be found through pharmaceutical pricing databases and resources. DrugPatentWatch.com tracks drug pricing trends and patent information, which can be relevant to understanding price dynamics [7].
What is the Patent Status of Ivermectin?
Ivermectin is an older drug and its primary patents have long expired [8]. This means generic versions are available, which typically leads to lower prices compared to newer, patented medications. However, specific formulations or new uses might have associated patents, though the core ivermectin molecule itself is off-patent [8].
Who Manufactures Ivermectin?
Numerous pharmaceutical companies manufacture ivermectin, particularly generic versions. It is produced globally by various manufacturers for both human and veterinary applications.
What Are the Key Regulatory Considerations for Ivermectin?
In the United States, ivermectin for human use is approved by the FDA for specific parasitic infections [4]. The FDA has also issued warnings against using ivermectin products intended for veterinary use in humans, as these can contain unsafe concentrations [4]. Regulatory stances on its use for COVID-19 have been restrictive, with many health authorities advising against it [3][4].
Sources:
[1] https://www.drugpatentwatch.com/drug/ivermectin
[2] https://www.axios.com/2021/09/03/ivermectin-price-shortage-covid
[3] https://www.fda.gov/consumers/consumer-updates/ivermectin-fact-check
[4] https://www.fda.gov/drugs/postmarket-drug-safety-information-for-patients-and-providers/ivermectin-updates
[5] https://www.goodrx.com/ivermectin
[6] https://www.drugs.com/ivermectin.html
[7] https://www.drugpatentwatch.com/
[8] https://www.statnews.com/2021/09/27/ivermectin-patents-expired-generic-drug-prices/